Loading company…
SkinVision BV is an Amsterdam-based health technology company whose mobile app helps detect skin cancer risk.
Founded in 2011 and headquartered in Amsterdam, Netherlands, SkinVision BV operates a mobile app that analyzes photos of moles and skin spots to help users check for skin cancer risk. It is offered on a subscription basis in the Netherlands, Belgium and the United Kingdom and has over 3 million users globally. The company has raised USD 7.60 mn in total, including a Series B on July 7, 2020 backed by LEO Pharma A/S and Personal Health Solutions Capital. The listed stage is Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in